GB Virus C: the Good Boy Virus?

Overview

Journal Trends Microbiol

Date 2012 Feb 14

PMID 22325031

Citations 71

Authors

Nirjal Bhattarai

Jack T Stapleton

Affiliations

Soon will be listed here.

Abstract

GB virus C (GBV-C) is a lymphotropic human virus discovered in 1995 that is related to hepatitis C virus (HCV). GBV-C infection has not been convincingly associated with any disease; however, several studies found an association between persistent GBV-C infection and improved survival in HIV-positive individuals. GBV-C infection modestly alters T cell homeostasis in vivo through various mechanisms, including modulation of chemokine and cytokine release and receptor expression, and by diminution of T cell activation, proliferation and apoptosis, all of which may contribute to improved HIV clinical outcomes. In vitro studies confirm these clinical observations and demonstrate an anti-HIV replication effect of GBV-C. This review summarizes existing data on potential mechanisms by which GBV-C interferes with HIV, and the research needed to capitalize on this epidemiological observation.

Citing Articles

Short-term antiretroviral therapy may not correct the dysregulations of plasma virome and cytokines induced by HIV-1 infection.

Ma Y, Zhang M, Wang Z, Cao L, Li Y, Wan Z Virulence. 2025; 16(1):2467168.

PMID: 39950859 PMC: 11866967. DOI: 10.1080/21505594.2025.2467168.

Viral Metagenomics in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): A Brazilian Experience.

de Campos G, de Mello Costa T, Silveira R, Valenca I, Bezerra R, Darrigo Junior L Microorganisms. 2025; 12(12.

PMID: 39770761 PMC: 11677183. DOI: 10.3390/microorganisms12122557.

Invasions of Host-Associated Microbiome Networks.

Murall C, Abbate J, Touzel M, Allen-Vercoe E, Alizon S, Froissart R Adv Ecol Res. 2024; 57:201-281.

PMID: 39404686 PMC: 7616576. DOI: 10.1016/bs.aecr.2016.11.002.

Large expansion of plasma commensal viruses is associated with SIV pathogenesis in .

Li Y, Song T, Cao L, Zhang H, Ma Y, Tian R Sci Adv. 2024; 10(40):eadq1152.

PMID: 39356751 PMC: 11446265. DOI: 10.1126/sciadv.adq1152.

Determinants of pegivirus persistence, cross-species infection, and adaptation in the laboratory mouse.

Nennig K, Murthy S, Maloney S, Shaw T, Sharobim M, Matkovic E PLoS Pathog. 2024; 20(8):e1012436.

PMID: 39196893 PMC: 11355568. DOI: 10.1371/journal.ppat.1012436.

References

Feldman S, Stein D, Amrute S, Denny T, Garcia Z, Kloser P . Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol. 2001; 101(2):201-10. DOI: 10.1006/clim.2001.5111. View

Moir S, Fauci A . B cells in HIV infection and disease. Nat Rev Immunol. 2009; 9(4):235-45. PMC: 2779527. DOI: 10.1038/nri2524. View

van der Bij A, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus R, Lange J . GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis. 2005; 191(5):678-85. DOI: 10.1086/427559. View

Yeo A, Matsumoto A, Hisada M, Shih J, Alter H, Goedert J . Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med. 2000; 132(12):959-63. DOI: 10.7326/0003-4819-132-12-200006200-00006. View

Zhang W, Chaloner K, Tillmann H, Williams C, Stapleton J . Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med. 2006; 7(3):173-80. DOI: 10.1111/j.1468-1293.2006.00366.x. View

Haynes B, Alam S . HIV-1 hides an Achilles' heel in virion lipids. Immunity. 2008; 28(1):10-2. PMC: 2673567. DOI: 10.1016/j.immuni.2007.12.005. View

Stapleton J, Chaloner K, Zhang J, Klinzman D, Souza I, Xiang J . GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS. 2009; 23(5):605-10. PMC: 2739595. DOI: 10.1097/QAD.0b013e32831f1b00. View

Dianzani U, Bensi T, Savarino A, Sametti S, Indelicato M, Mesturini R . Role of FAS in HIV infection. Curr HIV Res. 2004; 1(4):405-17. DOI: 10.2174/1570162033485131. View

Paredes R, Lopez Benaldo de Quiros J, Fernandez-Cruz E, Clotet B, Lane H . The potential role of interleukin-2 in patients with HIV infection. AIDS Rev. 2002; 4(1):36-40. View

10.

Lederman M, Penn-Nicholson A, Cho M, Mosier D . Biology of CCR5 and its role in HIV infection and treatment. JAMA. 2006; 296(7):815-26. DOI: 10.1001/jama.296.7.815. View

11.

Bhanich Supapol W, Remis R, Raboud J, Millson M, Tappero J, Kaul R . Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis. 2008; 197(10):1369-77. DOI: 10.1086/587488. View

12.

Levy J . The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol. 2001; 22(6):312-6. DOI: 10.1016/s1471-4906(01)01925-1. View

13.

Xiang J, George S, Wunschmann S, Chang Q, Klinzman D, Stapleton J . Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet. 2004; 363(9426):2040-6. DOI: 10.1016/S0140-6736(04)16453-2. View

14.

Lalle E, Sacchi A, Abbate I, Vitale A, Martini F, DOffizi G . Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol. 2008; 21(1):161-71. DOI: 10.1177/039463200802100118. View

15.

Nel A . T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy Clin Immunol. 2002; 109(5):758-70. DOI: 10.1067/mai.2002.124259. View

16.

Thomas D, Vlahov D, Alter H, Hunt J, Marshall R, Astemborski J . Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis. 1998; 177(3):539-42. DOI: 10.1086/514245. View

17.

Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H . Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition. J Virol. 2011; 85(14):7037-47. PMC: 3126597. DOI: 10.1128/JVI.02366-10. View

18.

Clerici M, Balotta C, Salvaggio A, Riva C, Trabattoni D, Papagno L . Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood. 1996; 88(2):574-9. View

19.

Rydze R, Xiang J, McLinden J, Stapleton J . GB virus type C infection polarizes T-cell cytokine gene expression toward a Th1 cytokine profile via NS5A protein expression. J Infect Dis. 2012; 206(1):69-72. PMC: 3415935. DOI: 10.1093/infdis/jis312. View

20.

Moore J, Kitchen S, Pugach P, Zack J . The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses. 2004; 20(1):111-26. DOI: 10.1089/088922204322749567. View